Literature DB >> 11471638

Immunohistochemical localization of tenascin, fibronectin, and type III collagen in human dental pulp.

E F Martinez1, S O Machado de Souza, L Corrêa, V Cavalcanti de Araújo.   

Abstract

The distribution of tenascin (TN), fibronectin (FN), and type III collagen (col III) in the extracellular matrix of the connective tissue of normal, inflamed, and hyalinized human dental pulp was studied by immunohistochemical staining with monoclonal antibodies against these molecules. TN, FN, and col III were present in all normal tissues studied. In areas of hyalinization only col III was observed. None of the molecules studied were seen in areas of inflammatory exudate. Strong staining for TN and FN was found in the periphery of all specimens analyzed next to the odontoblastic layer. We therefore conclude that TN, FN, and col III are present in the extracellular matrix of normal human dental pulp. TN, FN, and col III distribution in inflammatory and degenerative processes is different from that observed in normal human dental pulp.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11471638     DOI: 10.1097/00004770-200012000-00008

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  3 in total

1.  Ex-vivo recellularisation and stem cell differentiation of a decellularised rat dental pulp matrix.

Authors:  Manal Matoug-Elwerfelli; Hani Nazzal; El Mostafa Raif; Stacy-Paul Wilshaw; Filomena Esteves; Monty Duggal
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

2.  Biocompatibility and immunolabeling of fibronectin and tenascin of resinous root canal sealers.

Authors:  Vanessa Abreu Sanches Marques Costa; Carlos Roberto Emerenciano Bueno; Diego Valentim; Francine Benetti; Marina Tolomei Sandoval Cury; Ana Maria Veiga Vasques; Edilson Ervolino; Eloi Dezan-Junior
Journal:  J Conserv Dent       Date:  2022-01-13

3.  Type 2 diabetes and the clinically normal pulp: An in vitro study.

Authors:  Shaikhah Alsamahi; Trudy M Milne; Haizal Hussaini; Alison M Rich; Lara T Friedlander
Journal:  Int Endod J       Date:  2022-04-01       Impact factor: 5.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.